John M. Pritchard

496 total citations
17 papers, 367 citations indexed

About

John M. Pritchard is a scholar working on Molecular Biology, Immunology and Allergy and Cellular and Molecular Neuroscience. According to data from OpenAlex, John M. Pritchard has authored 17 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and Allergy and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in John M. Pritchard's work include Cell Adhesion Molecules Research (6 papers), Chemical Synthesis and Analysis (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). John M. Pritchard is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Chemical Synthesis and Analysis (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). John M. Pritchard collaborates with scholars based in United Kingdom, Ireland and Netherlands. John M. Pritchard's co-authors include Simon J. F. Macdonald, Anthony W. J. Cooper, George Papadatos, Craig Jamieson, Valerie J. Gillet, Stephen D. Pickett, Peter Willett, Allan J. B. Watson, Visakan Kadirkamanathan and Lisa Miller and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic & Biomolecular Chemistry and Journal of Chemical Information and Modeling.

In The Last Decade

John M. Pritchard

17 papers receiving 342 citations

Peers

John M. Pritchard
Susan Hubbell United States
Gary E. Aspnes United States
Carolyn A. Weigelt United States
Jag Heer United Kingdom
Jennifer L. Liras United States
Robert V. Moquin United States
Clive McCarthy United Kingdom
Susan Hubbell United States
John M. Pritchard
Citations per year, relative to John M. Pritchard John M. Pritchard (= 1×) peers Susan Hubbell

Countries citing papers authored by John M. Pritchard

Since Specialization
Citations

This map shows the geographic impact of John M. Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Pritchard more than expected).

Fields of papers citing papers by John M. Pritchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Pritchard. The network helps show where John M. Pritchard may publish in the future.

Co-authorship network of co-authors of John M. Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Pritchard. A scholar is included among the top collaborators of John M. Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Pritchard. John M. Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Procopiou, Panayiotis A., John W. Barrett, Richard J. D. Hatley, et al.. (2024). Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin Inhibitors. Journal of Medicinal Chemistry. 67(19). 17497–17519. 1 indexed citations
3.
Anderson, Niall A., Sébastien Campos, Royston C. B. Copley, et al.. (2019). Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis. Journal of Medicinal Chemistry. 62(19). 8796–8808. 8 indexed citations
5.
Miller, Lisa, John M. Pritchard, Simon J. F. Macdonald, Craig Jamieson, & Allan J. B. Watson. (2017). Emergence of Small-Molecule Non-RGD-Mimetic Inhibitors for RGD Integrins. Journal of Medicinal Chemistry. 60(8). 3241–3251. 37 indexed citations
6.
Miller, Lisa, Willem‐Jan Keune, Louise Young, et al.. (2016). Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode. Journal of Medicinal Chemistry. 60(2). 722–748. 29 indexed citations
7.
Anderson, Niall A., Ian B. Campbell, Brendan J. Fallon, et al.. (2016). Synthesis and determination of absolute configuration of a non-peptidic αvβ6 integrin antagonist for the treatment of idiopathic pulmonary fibrosis. Organic & Biomolecular Chemistry. 14(25). 5992–6009. 22 indexed citations
8.
Young, Louise, John M. Pritchard, Simon J. F. Macdonald, et al.. (2015). Identification of a novel class of autotaxin inhibitors through cross-screening. MedChemComm. 6(6). 1149–1155. 7 indexed citations
9.
Weller, Christian E. & John M. Pritchard. (2013). Evolving CJEU Jurisprudence: Balancing Sustainability Considerations with the Requirements of the Internal Market. European Procurement & Public Private Partnership Law Review. 8(1). 55–59. 3 indexed citations
10.
Papadatos, George, Valerie J. Gillet, Peter Willett, et al.. (2010). Lead Optimization Using Matched Molecular Pairs: Inclusion of Contextual Information for Enhanced Prediction of hERG Inhibition, Solubility, and Lipophilicity. Journal of Chemical Information and Modeling. 50(10). 1872–1886. 96 indexed citations
11.
Liddle, John, Paul Bamborough, Michael D. Barker, et al.. (2009). 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(9). 2504–2508. 25 indexed citations
12.
Papadatos, George, Anthony W. J. Cooper, Visakan Kadirkamanathan, et al.. (2008). Analysis of Neighborhood Behavior in Lead Optimization and Array Design. Journal of Chemical Information and Modeling. 49(2). 195–208. 21 indexed citations
13.
Johnston, Michael J., Haydn T. Jones, John M. Pritchard, et al.. (2005). Design and Synthesis of New Nonsteroidal Glucocorticoid Modulators through Application of an “Agreement Docking” Method. Journal of Medicinal Chemistry. 48(14). 4507–4510. 35 indexed citations
14.
Smith, Paul W., Anthony W. J. Cooper, Richard L. Bell, et al.. (1995). New Spiropiperidines as Potent and Selective Non-Peptide Tachykinin NK2 Receptor Antagonists. Journal of Medicinal Chemistry. 38(19). 3772–3779. 18 indexed citations
15.
Cooper, Anthony W. J., Richard L. Bell, Andrew B. McElroy, et al.. (1994). GR159897 and related analogues as highly potent, orally active non-peptide neurokinin NK2 receptor antagonists.. Bioorganic & Medicinal Chemistry Letters. 4(16). 1951–1956. 14 indexed citations
16.
Smith, Paul W., Andrew B. McElroy, John M. Pritchard, et al.. (1993). Low molecular weight neurokinin NK2 antagonists. Bioorganic & Medicinal Chemistry Letters. 3(5). 931–936. 13 indexed citations
17.
Hagan, R.M., I.J.M. Beresford, Peter J. Elliott, et al.. (1992). NK2 antagonists and the role of NK2 receptors. Regulatory Peptides. 37. S8–S8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026